Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 369716

Prediction of Alzheimer's disease in subjects with mild cognitive impairment using biological markers from CSF


Šimić, Goran
Prediction of Alzheimer's disease in subjects with mild cognitive impairment using biological markers from CSF // Neurologia Croatica 57 (Suppl. 4) / Šimić, Goran ; Mimica, Ninoslav ; Petravić, Damir (ur.).
Zagreb: Denona, 2008. str. 26-26 (pozvano predavanje, domaća recenzija, sažetak, znanstveni)


CROSBI ID: 369716 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Prediction of Alzheimer's disease in subjects with mild cognitive impairment using biological markers from CSF

Autori
Šimić, Goran

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Neurologia Croatica 57 (Suppl. 4) / Šimić, Goran ; Mimica, Ninoslav ; Petravić, Damir - Zagreb : Denona, 2008, 26-26

Skup
4th Croatian Congress on Alzheimer's disease with international participation

Mjesto i datum
Rovinj, Hrvatska, 08.10.2008. - 11.10.2008

Vrsta sudjelovanja
Pozvano predavanje

Vrsta recenzije
Domaća recenzija

Ključne riječi
Alzheimer's disease ; amyloid-beta ; cerebrospinal fluid ; dementia ; early diagnosis ; mild cognitive impairment ; tau protein

Sažetak
With the advent of new drugs such as gamma-secretase inhibitors, early detection of elderly subjects with mild cognitive impairment (MCI) who are destined to develop AD is becoming increasingly important. For this purpose, the three most commonly used CSF biomarkers (total tau, amyloid-ß42 protein and phosphorylated tau protein) have been evaluated in numerous studies, including ours. Majority of these investigations confirmed that CSF markers have high sensitivity to differentiate early and incipient AD from normal aging, major depressive disorder, alcoholic dementia and Parkinson’ s disease, but relatively lower specificity against other primary causes of dementia syndrome, such as frontotemporal and Lewy body dementia. In most studies, low amyloid-ß42 and high total tau protein in cerebrospinal fluid were found in about 90% of the MCI cases that progressed to AD as compared with the 10% stable MCI cases. Similarly, higher concentrations of tau protein phosphorylated on threonine 231 were found in MCI cohort that progressed to AD compared to those with stable MCI. It is concluded that pathological levels of two or more CSF markes can reliably predict MCI conversion to AD and correctly identify the stable form of MCI.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Psihologija



POVEZANOST RADA


Projekti:
108-1081870-1942 - Fosforilacija tau proteina u razvitku i Alzheimerovoj bolesti (Šimić, Goran, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Goran Šimić (autor)


Citiraj ovu publikaciju:

Šimić, Goran
Prediction of Alzheimer's disease in subjects with mild cognitive impairment using biological markers from CSF // Neurologia Croatica 57 (Suppl. 4) / Šimić, Goran ; Mimica, Ninoslav ; Petravić, Damir (ur.).
Zagreb: Denona, 2008. str. 26-26 (pozvano predavanje, domaća recenzija, sažetak, znanstveni)
Šimić, G. (2008) Prediction of Alzheimer's disease in subjects with mild cognitive impairment using biological markers from CSF. U: Šimić, G., Mimica, N. & Petravić, D. (ur.)Neurologia Croatica 57 (Suppl. 4).
@article{article, author = {\v{S}imi\'{c}, Goran}, year = {2008}, pages = {26-26}, keywords = {Alzheimer's disease, amyloid-beta, cerebrospinal fluid, dementia, early diagnosis, mild cognitive impairment, tau protein}, title = {Prediction of Alzheimer's disease in subjects with mild cognitive impairment using biological markers from CSF}, keyword = {Alzheimer's disease, amyloid-beta, cerebrospinal fluid, dementia, early diagnosis, mild cognitive impairment, tau protein}, publisher = {Denona}, publisherplace = {Rovinj, Hrvatska} }
@article{article, author = {\v{S}imi\'{c}, Goran}, year = {2008}, pages = {26-26}, keywords = {Alzheimer's disease, amyloid-beta, cerebrospinal fluid, dementia, early diagnosis, mild cognitive impairment, tau protein}, title = {Prediction of Alzheimer's disease in subjects with mild cognitive impairment using biological markers from CSF}, keyword = {Alzheimer's disease, amyloid-beta, cerebrospinal fluid, dementia, early diagnosis, mild cognitive impairment, tau protein}, publisher = {Denona}, publisherplace = {Rovinj, Hrvatska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font